What is InsiderStreet.ai?

InsiderStreet.ai is a free financial intelligence platform tracking smart-money signals — insider trades, congressional stock disclosures, hedge fund positions, ETF flows, dark pool activity, and short interest — across 88,000+ securities.

How do I track which hedge funds own a stock?

On any stock page on InsiderStreet, the Hedge Fund Holders tab shows every fund holding that stock — names, position size, quarterly changes, and fund flows. Data is sourced from SEC institutional ownership disclosures.

How do I see which Congress members trade a stock?

Each stock page has a Smart Money tab that shows congressional disclosures under the STOCK Act — senators and representatives, transaction type, date, and dollar range — typically disclosed within 45 days of the trade.

ZBH vs PEN vs SNN

161 measures in 16 categories, one definition each, computed from filings and market data.

ZBH59.6

Zimmer Biomet Holdings, Inc.

Healthcare · Medical - Devices

$94.98 +0.63%$18.1B mkt cap

Score DNA

PEN68.2

Penumbra, Inc.

Healthcare · Medical - Devices

$320.86 −0.09%$12.6B mkt cap

Score DNA

SNN75.7

Smith & Nephew plc

Healthcare · Medical - Devices

$29.06 −0.10%$12.2B mkt cap

Score DNA

Price, rebased to 100 three years ago

ZBH PEN SNN · weekly adjusted closes

Smart money 8 Valuation 16 Profitability (TTM) 12 Returns on capital 11 Growth 17 Margin history & stability 7 Liquidity (latest quarter) 7 Leverage & solvency (latest quarter) 13 Efficiency 11 Cash flow & earnings quality 7 Dividends & buybacks 9 Scores & forensic checks 15 Per share 7 Size (TTM) 8 Price performance 9 Technicals 4

● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.

Smart money

8 measures

Measure	ZBH	PEN	SNN
Insider open-market buys, 180d	0	0	0
Insider $ bought, 180d	—	—	—
Congress purchases, 180d	2	0	0
Last Congress purchase	2026-09-11	—	—
13F net change in holders	+1	−30	+16
ETFs adding shares, 30d	913	247	33
ETFs trimming, 30d	777	164	20
Net ETF funds, 30d	+136	+83	+13

Valuation

16 measures

Measure	ZBH	PEN	SNN
P/E (TTM)	22.5x 33rd	78.7x 96th	10.8x 4th
PEG (P/E ÷ 3-yr EPS CAGR)	1.11 47th	1.03 40th	0.38 20th
Price / sales	2.1x 23rd	8.4x 85th	1.0x 8th
Price / book	1.4x 16th	8.3x 80th	2.3x 30th
Price / tangible book	—	9.2x 63rd	15.5x 80th
Price / free cash flow	9.9x 11th	58.5x 86th	7.4x 0th
Price / operating cash flow	10.4x 14th	45.5x 86th	4.9x 5th
Enterprise value	$25.2B 88th	$12.2B 85th	$15.2B 87th
EV / sales	3.0x 42nd	8.1x 87th	1.2x 8th
EV / EBITDA	11.3x 29th	54.9x 89th	5.0x 3rd
EV / EBIT	20.5x 42nd	59.5x 85th	8.5x 3rd
EV / free cash flow	13.8x 14th	56.5x 78th	9.2x 3rd
Earnings yield	4.5% 85th	1.3% 57th	9.3% 98th
FCF yield	10.1% 93rd	1.7% 48th	13.6% 100th
Operating cash flow yield	9.6% 90th	2.2% 38th	20.4% 97th
Graham number (per share)	$78.52 81st	$59.43 70th	$26.63 26th

Profitability (TTM)

12 measures

Measure	ZBH	PEN	SNN
Gross margin	69.9% 68th	67.8% 58th	68.2% 63rd
EBITDA margin	26.2% 88th	14.7% 63rd	24.8% 85th
Operating margin	15.7% 80th	12.4% 70th	14.5% 77th
EBIT margin	14.4% 77th	13.6% 72nd	14.5% 78th
Net margin	9.5% 73rd	10.7% 77th	9.2% 70th
NOPAT margin	13.6% 80th	9.8% 67th	11.7% 70th
FCF margin	21.5% 90th	14.3% 77th	13.5% 72nd
Operating cash flow margin	20.5% 80th	18.5% 73rd	20.3% 78th
R&D / revenue	5.2% 22nd	6.1% 29th	4.9% 20th
SG&A / revenue	40.3% 33rd	49.3% 52nd	49.7% 55th
Stock comp / revenue	1.2% 17th	4.0% 52nd	0.4% 3rd
Effective tax rate	13.6% 9th	21.2% 76th	19.8% 17th

Returns on capital

11 measures

Measure	ZBH	PEN	SNN
ROE (on average equity)	6.4% 63rd	11.4% 75th	21.7% 92nd
ROA	3.5% 63rd	8.8% 83rd	10.5% 88th
ROIC	5.9% 61st	13.6% 80th	17.4% 83rd
ROCE	6.2% 58th	11.8% 82nd	19.9% 93rd
Return on tangible assets	5.4% 60th	11.2% 85th	16.5% 95th
Cash ROIC (OCF / invested capital)	8.9% 58th	25.6% 86th	30.3% 93rd
Gross profitability (GP / assets)	26.1% 28th	51.7% 68th	76.9% 93rd
ROIC, 3-yr average	4.6% 61st	9.7% 78th	11.9% 86th
ROIC, 5-yr average	3.7% 59th	6.8% 67th	17.3% 88th
ROE, 5-yr average	5.4% 65th	4.8% 62nd	21.5% 90th
Incremental ROIC	—	13.6% 49th	961.9% 96th

Growth

17 measures

Measure	ZBH	PEN	SNN
Revenue growth (TTM YoY)	8.6% 41st	17.6% 70th	11.5% 50th
Revenue growth (QoQ)	4.3% 28th	4.1% 27th	-2.9% 3rd
Revenue CAGR, 3 yr	5.7% 26th	17.1% 68th	8.4% 36th
Revenue CAGR, 5 yr	2.9% 10th	17.5% 67th	5.8% 25th
Gross profit CAGR, 3 yr	4.8% 19th	19.9% 73rd	6.5% 27th
Operating income CAGR, 3 yr	15.3% 60th	73.0% 92nd	4.1% 24th
Net income growth (TTM YoY)	-2.0% 42nd	8.7% 50th	115.6% 96th
Net income CAGR, 3 yr	16.9% 65th	76.7% 90th	1.2% 25th
EPS growth (TTM YoY)	0.8% 42nd	7.8% 50th	118.7% 96th
EPS CAGR, 3 yr	20.2% 60th	76.1% 90th	28.3% 75th
EPS CAGR, 5 yr	-0.8% 30th	57.2% 100th	22.4% 80th
FCF growth (TTM YoY)	28.5% 53rd	33.6% 60th	412.1% 100th
FCF CAGR, 3 yr	21.1% 38th	650.9% 100th	14.2% 23rd
Operating cash flow CAGR, 3 yr	8.9% 23rd	146.0% 100th	9.9% 29th
Book value CAGR, 3 yr	3.6% 47th	12.4% 71st	28.6% 94th
Dividend CAGR, 3 yr	2.1% 38th	—	27.2% 100th
Sustainable growth rate	4.9% 26th	11.4% 56th	9.0% 37th

Margin history & stability

7 measures

Measure	ZBH	PEN	SNN
Gross margin, 3-yr average	70.9% 74th	65.6% 55th	70.1% 70th
Operating margin, 3-yr average	16.1% 83rd	7.7% 57th	13.7% 75th
Net margin, 3-yr average	11.1% 79th	7.8% 66th	8.0% 70th
FCF margin, 3-yr average	18.1% 94th	12.2% 75th	9.1% 62nd
Revenue stability (0-1)	0.66 15th	0.99 91st	0.88 47th
Earnings stability (0-1)	0.10 17th	0.72 81st	0.08 15th
Margin stability (0-1)	0.99 96th	0.96 55th	0.97 77th

Liquidity (latest quarter)

7 measures

Measure	ZBH	PEN	SNN
Cash & short-term investments	$410.0M 67th	$658.8M 83rd	$754.0M 85th
Net cash (− = net debt)	−$7.1B 8th	$446.1M 92nd	−$3.0B 10th
Working capital	$2.1B 92nd	$1.1B 82nd	$2.3B 93rd
Current ratio	1.69 18th	5.75 80th	2.14 32nd
Quick ratio	1.69 37th	3.86 72nd	1.11 20th
Cash ratio (cash + ST investments / current liabilities)	0.14 12th	2.82 70th	0.37 23rd
Defensive interval (days)	173 days 15th	372 days 65th	122 days 7th

Leverage & solvency (latest quarter)

13 measures

Measure	ZBH	PEN	SNN
Total debt	$7.5B 92nd	$212.7M 43rd	$3.8B 90th
Debt / equity	0.59 54th	0.14 28th	0.73 65th
Net debt / equity	0.56 68th	−0.29 28th	0.59 70th
Debt / assets	32.8% 63rd	10.8% 28th	34.4% 67th
Debt / capital	37.2% 54th	12.2% 28th	42.2% 65th
Debt / EBITDA	3.36 61st	0.96 21st	1.24 32nd
Net debt / EBITDA	3.17 66th	−2.01 11th	1.00 37th
Interest coverage (EBIT / interest)	4.3x 65th	157.7x 94th	5.9x 75th
Cash interest coverage	6.0x 67th	213.9x 94th	8.2x 77th
Debt payback (years of OCF)	4.3 yrs 58th	0.8 yrs 19th	1.5 yrs 26th
Liabilities / assets	44.6% 42nd	22.5% 15th	53.0% 58th
IS credit model rating	BBB	AAA	AA-
Implied credit spread (bps)	275 53rd	50 0th	100 22nd

Efficiency

11 measures

Measure	ZBH	PEN	SNN
Asset turnover	0.37 10th	0.82 77th	1.14 97th
Fixed asset turnover	3.80 28th	4.45 41st	7.59 79th
Inventory turnover	2.1 67th	1.1 10th	1.6 38th
Receivables turnover	5.0 25th	8.2 87th	8.6 90th
Days sales outstanding	73 days 75th	44 days 13th	42 days 10th
Days inventory outstanding	175 days 33rd	328 days 90th	222 days 62nd
Days payables outstanding	50 days 47th	27 days 8th	109 days 85th
Cash conversion cycle (days)	197 days 45th	345 days 95th	155 days 35th
Capex / revenue	—	4.1% 60th	6.8% 86th
Capex / depreciation	—	3.61 98th	0.66 47th
Operating expense ratio	55.8% 41st	57.4% 51st	56.4% 42nd

Cash flow & earnings quality

7 measures

Measure	ZBH	PEN	SNN
Operating cash flow / net income	2.16 78th	1.73 59th	2.21 81st
FCF / net income	2.27 89th	1.34 52nd	1.47 67th
FCF / operating cash flow	—	77.7% 64th	66.5% 52nd
Capex / operating cash flow	—	22.3% 36th	33.5% 48th
Accruals ratio	-4.1% 63rd	-6.4% 38th	-12.6% 18th
Sloan accruals ratio	-5.6% 32nd	10.2% 88th	-14.9% 8th
Earnings quality score (0-1)	1.00 48th	0.75 4th	0.75 4th

Dividends & buybacks

9 measures

Measure	ZBH	PEN	SNN
Dividend yield	1.0% 92nd	0.0% 0th	2.7% 98th
Dividend per share (TTM)	$0.96 93rd	$0.00 0th	$0.79 92nd
Payout ratio (dividends / net income)	23.4% 81st	0.0% 0th	58.6% 89th
Dividends / FCF	10.3% 75th	0.0% 0th	40.0% 86th
Dividend growth (YoY)	0.7% 22nd	—	2.5% 44th
Buyback yield	2.8% 87th	0.0% 58th	5.1% 98th
Shareholder yield (dividends + buybacks)	3.9% 92nd	0.0% 53rd	10.5% 98th
Share count change (YoY)	-2.8% 9th	0.8% 46th	-1.5% 20th
Buybacks, last 5 years	$2.0B 93rd	$103.0M 68th	$1.2B 85th

Scores & forensic checks

15 measures

Measure	ZBH	PEN	SNN
IS score	60 73rd	68 87th	76 95th
IS profitability	45 62nd	51 77th	64 85th
IS growth	44 23rd	59 48th	67 64th
IS value	65 93rd	30 15th	81 98th
IS momentum	74 61st	86 80th	92 89th
IS risk (safety)	50 35th	100 62nd	90 58th
IS quality	72 67th	78 72nd	82 83rd
IS balance sheet	50 47th	93 93rd	64 68th
IS earnings quality	71 70th	75 80th	63 62nd
IS cash flow	77 87th	80 90th	70 78th
Piotroski F-score (0-9)	6 47th	6 47th	8 83rd
Altman Z-score	2.4 37th	18.9 92nd	3.9 60th
Beneish M-score	−2.59 61st	−2.75 29th	−2.95 20th
Ohlson O-score	−8.82 27th	−10.83 10th	−9.02 23rd
IS credit score	57 43rd	96 95th	81 75th

Per share

7 measures

Measure	ZBH	PEN	SNN
EPS, diluted (TTM)	$4.18 88th	$4.06 85th	$2.62 73rd
Book value per share	$65.48 97th	$38.68 87th	$12.04 58th
Tangible book per share	−$9.10 3rd	$34.55 95th	$1.98 48th
Revenue per share	$44.13 87th	$38.03 82nd	$28.48 75th
FCF per share	$9.49 93rd	$5.46 88th	$3.84 77th
Operating cash flow per share	$9.04 92nd	$7.02 87th	$5.78 80th
Cash per share	$2.13 43rd	$16.65 95th	$1.75 37th

Size (TTM)

8 measures

Measure	ZBH	PEN	SNN
Market cap	$18.1B 88th	$12.6B 87th	$12.2B 85th
Revenue	$8.5B 90th	$1.5B 67th	$12.3B 92nd
EBITDA	$2.2B 90th	$221.9M 67th	$3.0B 92nd
Net income	$806.8M 87th	$160.6M 75th	$1.1B 92nd
Free cash flow	$1.8B 93rd	$215.9M 75th	$1.7B 92nd
Total assets	$22.8B 92nd	$2.0B 60th	$11.0B 88th
Shareholders' equity	$12.6B 93rd	$1.5B 72nd	$5.2B 85th
Employees	17,000 88th	4,700 65th	18,362 90th

Price performance

9 measures

Measure	ZBH	PEN	SNN
1 day	+0.6%	−0.1%	−0.1%
1 week	+6.5%	+0.5%	+6.7%
1 month	+1.0%	+0.6%	+5.9%
3 months	+5.8%	+0.9%	−3.4%
6 months	+0.2%	−3.4%	−14.4%
Year to date	+5.5%	+3.7%	−9.2%
1 year	−4.4%	+27.0%	−15.6%
3 years, cumulative	−8.4%	+48.9%	+36.1%
5 years, cumulative	−31.2%	+25.7%	−2.7%

Technicals

4 measures

Measure	ZBH	PEN	SNN
RSI 14	57.5	56.6	69.6
From 52-week high	−11.1%	−11.4%	−20.4%
From 52-week low	+20.0%	+45.0%	+11.5%
Beta	0.48	0.70	0.69

InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17

ZBH vs PEN vs SNN

Price, rebased to 100 three years ago

Smart money

Valuation

Profitability (TTM)

Returns on capital

Growth

Margin history & stability

Liquidity (latest quarter)

Leverage & solvency (latest quarter)

Efficiency

Cash flow & earnings quality

Dividends & buybacks

Scores & forensic checks

Per share

Size (TTM)

Price performance

Technicals

Sign in to InsiderStreet